The success of mRNA vaccine technology as seen during the recent Covid-19 pandemic offers hope for using the platform to reduce preventable illness across multiple disease areas, according to a report on Wednesday.

The report by GlobalData, a data and analytics company, as part of World Immunization Week, shows that there are about 507 prophylactic or preventive vaccines currently in late-stage development, of which 88 are being developed using the mRNA technology to prevent diseases ranging from tuberculosis, malaria, to influenza, Covid-19, respiratory syncytial virus (RSV) and Lyme disease, amongst others.